Functional benefit of CRISPR-Cas9-induced allele deletion for
CRISPR-Cas9
MT: RNA/DNA Editing
SNP
allele deletion
calcium release
dominant mutation
gene therapy
myopathy
ryanodine receptor
Journal
Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621
Informations de publication
Date de publication:
10 Sep 2024
10 Sep 2024
Historique:
received:
08
02
2024
accepted:
14
06
2024
medline:
29
7
2024
pubmed:
29
7
2024
entrez:
29
7
2024
Statut:
epublish
Résumé
More than 700 pathogenic or probably pathogenic variations have been identified in the
Identifiants
pubmed: 39071953
doi: 10.1016/j.omtn.2024.102259
pii: S2162-2531(24)00146-X
pmc: PMC11278293
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102259Informations de copyright
© 2024 The Author(s).
Déclaration de conflit d'intérêts
The authors declare no competing interests.